Navigation Links
P&G Reports First Quarter EPS of $1.03 Up 12% on 9% Sales Growth
Date:10/29/2008

arnings. Capital expenditures were 3.2% of net sales during the quarter.

The company reiterated that it maintains credit ratings in the top five percent of all publicly traded companies which should allow the company to continue accessing credit markets without issue.

Business Segment Discussion

The following provides perspective on the company's July - September quarter results by business segment.

Beauty GBU

-- Beauty net sales increased 12 percent during the quarter to $5.1 billion. Net sales were up due to a four percent increase in volume, a two percent pricing impact and a six percent favorable foreign exchange impact. Hair Care volume grew mid-single digits behind strong growth in developing regions. Globally, all major retail hair care brands contributed to volume growth led by mid-single digit growth of Pantene and double-digit growth of Head & Shoulders and Rejoice. This was partially offset by a low-single digit decline in Professional Hair Care. Cosmetics volume grew double digits behind continued growth of Cover Girl. Skin Care volume grew low-single digits due to double-digit growth of SK-II. Prestige Fragrances volume declined low- single digits due mainly to a shift in initiative timings to the second half of fiscal 2009. Earnings grew nine percent during the quarter to $754 million as sales growth and lower SG&A expenses as a percentage of net sales were partially offset by reduced gross margin from higher commodity costs.

-- Grooming net sales were up six percent to $2.1 billion for the quarter. Volume declined one percent due to a double-digit decline of Braun. Blades & Razors volume grew low-single digits as double-digit growth of Gillette Fusion and high-single digit growth of Venus were mostly offset by declines in legacy shaving systems. Global market share of the blades and razors category increased slightly for the quarter. Braun volume was down due to a double- digit decline of male hair removers, t
'/>"/>

SOURCE The Procter & Gamble Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine news :

1. Cardinal Health Reports First Quarter Results
2. uKarma Reports Progress With International Distribution Agreement for Its Xflowsion DVD Series
3. STAAR Surgical Reports 33% Third Quarter Revenue Growth
4. BioCryst Reports Positive Results From a Phase 2 Study of Intravenous Peramivir for Outpatient Influenza
5. Cynosure Reports 21% Revenue Growth for the Third Quarter of 2008
6. LCA-Vision Reports Third Quarter 2008 Financial Results
7. Universal Health Services, Inc. Reports 2008 Third Quarter Results
8. PAREXEL Reports First Quarter Fiscal Year 2009 Financial Results
9. Sharps Compliance Corp. Reports Net Income More Than Doubles on 26% Increase in Revenue in the First Quarter of Fiscal 2009
10. WellPoint Reports Third Quarter 2008 Results
11. Forest Laboratories, Inc. Reports Fiscal Second Quarter 2009 Earnings per Share of $0.80
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...Results of St. Jude study could shape new treatmen...Jan. 8 Scientists at St...ted a more effective treatment for bacterial pneum...biotics clindamycin and azithromycin, which kill b... more effective than a standard first-line treatme...
(Date:1/8/2009)...ew says it lowered bad cholesterol more effectivel...hDay News) -- After nearly a year of review, U.S. ... the continued use of the controversial cholestero...ug Administration said there was no significant di...nts taking Vytorin and patients taking the drug Zo...
(Date:1/8/2009)...BETHESDA, Md., Jan. 8 H...ased to announce that throughout the fourth quarte...rthotics Center, Rocky Mountain Orthotic-Prostheti...vices, Inc., First Coast Orthotics & Prostheti...hese acquisitions add patient care centers to exis...
(Date:1/8/2009)... SAN FRANCISCO, Jan. 8 /PRNewswire-FirstCall/ -...ced that David Hung, M.D., president and chief,ex....P. Morgan Healthcare,Conference on Wednesday, Ja...,St. Francis Hotel in San Francisco. , Dr....ts clinical,development programs for Dimebon for ...
Breaking Medicine News(10 mins):Health News:Study Finds More Effective Treatment for Pneumonia Following Influenza 2Health News:Study Finds More Effective Treatment for Pneumonia Following Influenza 3Health News:FDA Backs Cholesterol Drug Vytorin 2Health News:Hanger Orthopedic Group, Inc. Announces Six Acquisitions Totaling $8.9 Million of Annual Net Revenue 2Health News:Medivation Announces Participation in 27th Annual J.P. Morgan Healthcare Conference 2
...ording to the author of the study, James Raftery, ...d that NICE is being partial with its decisions//....cellence (NICE) was set up as an independent body ...etting the best from NHS resources. It examines th...
...und 26,000 candidates would appear in the entrance...tigious Jawaharlal Nehru Institute of Post Graduat... These candidates will sit for the two-and-a-half...usly in Pondicherry, New Delhi, Chennai, Hyderabad...
...Wheeling Jesuit University some researchers found ...ood for keeping brain alert, controls impulses// a...e lovers were found to have better cognitive abili...alue to the above study, an under graduate student...
...a yoga techniques, the Chinese Tai chi and various...y health care programme held here on May 28 by the....// Conducted by Dr Girish Patel, secretary of th... ist by profession, the programme will deal with ...
Other Medicine News:
(Date:1/8/2009)...ated at the initial dose in an ongoing Phase Ib tr...line after three days , , Conference Call Today...re-FirstCall/ -- Anadys Pharmaceuticals, Inc. (Nas...st cohort of an ongoing Phase Ib clinical trial of...ide polymerase inhibitor. ANA598 was very well-to...
(Date:1/7/2009)...eral Products in Development Based On Osteotech,s ... Natural BioRegeneration; FDA Filing Anticipated i... 7 Osteotech, Inc. (Na...biologic products for regenerative healing, announ... trial for its DuraTech(TM) BioRegeneration Matrix...
(Date:1/6/2009)...., Jan. 6 In recent controlled stu... of Memphis , scientists found that the patented i...irst and only proven ingredient to increase levels...ing blood nitrate/nitrate (NOx) in human subjects....bles an increase in blood flow to the skeletal mus...
(Date:1/6/2009)...rance, January 6 , ...ollaboration Until,December 2011 , - Expan...Antibody,Discovery in Ophthalmology , - Re...Allergan,Sublicenses to a Third Party , ...unced a reinforcement,of its existing drug discov...
Breaking Medicine Technology:ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 2ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 3ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 4ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 5ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 6Osteotech Initiates Pivotal Clinical Trial for DuraTech(TM) BioRegeneration Matrix 2Osteotech Initiates Pivotal Clinical Trial for DuraTech(TM) BioRegeneration Matrix 3US Testing Proves Glyc'n Go(TM) Increases NO in the Blood Stream 2ExonHit Therapeutics Expands Strategic Collaboration With Allergan 2ExonHit Therapeutics Expands Strategic Collaboration With Allergan 3ExonHit Therapeutics Expands Strategic Collaboration With Allergan 4US Oncology Announces Resignation of Chief Financial Officer 4706 1Talk Therapy Proves Effective for Terminal Cancer Patients 17223 1Talk Therapy Proves Effective for Terminal Cancer Patients 17223 2Masimo to Report First Quarter 2008 Financial Results on April 29 2008 17220 1Masimo to Report First Quarter 2008 Financial Results on April 29 2008 17220 221st Congress of the College of Neuropsychopharmacology 17215 121st Congress of the College of Neuropsychopharmacology 17215 2
...ger, M.D., Ph.D. Contributing Editor Harvard Medic...art failure in African American patients has under...ifferently to the same medication. This concept h...ns, and in many cases is due to individual genetic...ses on these issues, valuable new laboratory tools...
.... Contributing Editor The outcome of many illnesse... units (ICUs) has not improved dramatically over t...ech monitors and sophisticated mechanical and phar...d, critically ill patients requiring intensive car...f death and substantial morbidity. Recently, howe...
Other Medicine Technology:Gene Chips to Detect CYP Variations: A New Step Toward Customized Medical Therapy. 2Gene Chips to Detect CYP Variations: A New Step Toward Customized Medical Therapy. 3Tight Glycemic Control in the ICU 2Tight Glycemic Control in the ICU 3
...able laparoscopic 12 mm linear cutting stapler for...ium staples., ,The stapler places two triple, sta... the knife divides the tissue in between. The inst...e surgical procedure: it can be reloaded up to 7 t...
...g unit for reloadable rotating (360°) linear s...tion and anastomosis with titanium staples., ,The...nium staples and simultaneously the knife divides ...for multiple use during a single surgical procedur...
ENDO GIA ROTICULATOR™ Single Use Loading Units with Titanium Staples for use with the ENDO GIA™ Universal and GIA™ Universal Instrument (030403) Single Use Instrument (030449).
... Thoracic Endoscopic Linear Cutter has application...urgical procedures for transection, resection, and...taple line buttressing materials such as bovine pe... for a total of eight firings. Different cartridge...
Medicine Products: